Total Payments
$1,083
2023 Payments
$44.76
Companies
15
Transactions
63
Medicare Patients
5,952
Medicare Billing
$282,997
Payment Breakdown by Category
Food & Beverage$1,025 (94.7%)
Education$57.45 (5.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,025 | 59 | 94.7% |
| Education | $57.45 | 4 | 5.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $242.20 | 16 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $238.24 | 11 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $172.66 | 8 | $0 (2018) |
| Actelion Pharmaceuticals US, Inc. | $131.72 | 9 | $0 (2023) |
| Mylan Specialty L.P. | $71.29 | 4 | $0 (2018) |
| Sunovion Pharmaceuticals Inc. | $56.59 | 3 | $0 (2018) |
| Circassia Pharmaceuticals Inc | $36.81 | 2 | $0 (2017) |
| PFIZER INC. | $25.85 | 2 | $0 (2018) |
| Genentech USA, Inc. | $20.26 | 1 | $0 (2018) |
| Teva Pharmaceuticals USA, Inc. | $18.67 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $44.76 | 2 | GlaxoSmithKline, LLC. ($29.41) |
| 2022 | $53.58 | 3 | Actelion Pharmaceuticals US, Inc. ($28.55) |
| 2021 | $32.97 | 2 | United Therapeutics Corporation ($18.11) |
| 2020 | $11.56 | 1 | AstraZeneca Pharmaceuticals LP ($11.56) |
| 2019 | $42.61 | 3 | Actelion Pharmaceuticals US, Inc. ($42.61) |
| 2018 | $580.02 | 34 | AstraZeneca Pharmaceuticals LP ($159.32) |
| 2017 | $317.06 | 18 | AstraZeneca Pharmaceuticals LP ($67.36) |
All Payment Transactions
63 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/02/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $29.41 | General |
| Category: IMMUNOLOGY | ||||||
| 01/20/2023 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Cardiology | ||||||
| 12/07/2022 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $12.57 | General |
| Category: Cardiology | ||||||
| 10/03/2022 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: Cardiology | ||||||
| 04/30/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $25.03 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2021 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: Cardiology | ||||||
| 10/08/2021 | United Therapeutics Corporation | TYVASO (Drug) | Education | In-kind items and services | $18.11 | General |
| Category: PAH | ||||||
| 11/11/2020 | AstraZeneca Pharmaceuticals LP | BREZTRI AEROSPHERE (Drug) | Education | In-kind items and services | $11.56 | General |
| Category: Respiratory | ||||||
| 07/09/2019 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Cardiology | ||||||
| 06/06/2019 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: Cardiology | ||||||
| 05/30/2019 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Cardiology | ||||||
| 12/19/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $6.19 | General |
| Category: RESPIRATORY | ||||||
| 12/08/2018 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $22.47 | General |
| Category: Respiratory | ||||||
| 11/02/2018 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: RESPIRATORY | ||||||
| 10/04/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: ONCOLOGY | ||||||
| 09/13/2018 | PFIZER INC. | PREVNAR - 13 (Biological) | Food and Beverage | In-kind items and services | $11.00 | General |
| Category: VACCINES | ||||||
| 08/10/2018 | Genentech USA, Inc. | Esbriet (Biological) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: Immunology | ||||||
| 08/02/2018 | Sunovion Pharmaceuticals Inc. | Utibron (Drug), Seebri, Lonhala Magnair | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: Respiratory | ||||||
| 07/26/2018 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $10.44 | General |
| Category: RESPIRATORY | ||||||
| 07/25/2018 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $11.57 | General |
| Category: Respiratory | ||||||
| 07/13/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT, SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: RESPIRATORY | ||||||
| 07/12/2018 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: RESPIRATORY | ||||||
| 07/10/2018 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: Respiratory | ||||||
| 06/29/2018 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: RESPIRATORY | ||||||
| 06/14/2018 | Shire North American Group Inc | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,307 | 1,604 | $363,817 | $68,230 |
| 2022 | 15 | 1,732 | 2,013 | $341,813 | $73,171 |
| 2021 | 16 | 1,577 | 1,835 | $333,680 | $72,283 |
| 2020 | 12 | 1,336 | 1,628 | $244,160 | $69,314 |
Total Patients
5,952
Total Services
7,080
Medicare Billing
$282,997
Procedure Codes
69
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 264 | 466 | $159,856 | $34,887 | 21.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 197 | 275 | $64,256 | $12,911 | 20.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 52 | 52 | $26,728 | $5,150 | 19.3% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 151 | 152 | $26,752 | $2,723 | 10.2% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 152 | 153 | $19,584 | $2,551 | 13.0% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 148 | 149 | $24,585 | $2,120 | 8.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 13 | 13 | $8,411 | $1,889 | 22.5% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 86 | 86 | $7,998 | $1,699 | 21.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 21 | 23 | $4,409 | $1,329 | 30.1% |
| G0296 | Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | Office | 2023 | 45 | 48 | $3,600 | $1,215 | 33.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 53 | 59 | $1,180 | $495.60 | 42.0% |
| 94618 | Test for exercise-induced lung stress | Facility | 2023 | 20 | 20 | $1,572 | $336.49 | 21.4% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2023 | 30 | 30 | $3,710 | $276.95 | 7.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 32 | 32 | $5,280 | $252.96 | 4.8% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 31 | 31 | $5,296 | $212.40 | 4.0% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 12 | 15 | $600.00 | $181.22 | 30.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 250 | 398 | $111,440 | $29,398 | 26.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 201 | 288 | $54,720 | $14,893 | 27.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 79 | 105 | $10,233 | $6,420 | 62.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 34 | 34 | $12,580 | $3,861 | 30.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 31 | 31 | $13,175 | $3,198 | 24.3% |
| 94617 | Test for exercise-induced spasm of lung airways | Facility | 2022 | 128 | 128 | $15,360 | $3,165 | 20.6% |
| 94618 | Test for exercise-induced lung stress | Facility | 2022 | 148 | 148 | $6,660 | $2,583 | 38.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 17 | 17 | $8,925 | $2,262 | 25.3% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2022 | 231 | 232 | $26,680 | $2,171 | 8.1% |
About Dr. Devi Vedula, M.D
Dr. Devi Vedula, M.D is a Pulmonary Disease healthcare provider based in Brockton, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1922045665.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Devi Vedula, M.D has received a total of $1,083 in payments from pharmaceutical and medical device companies, with $44.76 received in 2023. These payments were reported across 63 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,025).
As a Medicare-enrolled provider, Vedula has provided services to 5,952 Medicare beneficiaries, totaling 7,080 services with total Medicare billing of $282,997. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Brockton, MA
- Active Since 06/01/2006
- Last Updated 05/27/2015
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1922045665
Products in Payments
- FASENRA (Drug) $159.32
- UPTRAVI (Drug) $118.28
- NUCALA (Biological) $77.32
- BEVESPI AEROSPHERE (Drug) $67.36
- TRELEGY ELLIPTA (Drug) $64.96
- Dymista (Drug) $55.94
- ANORO (Drug) $48.25
- STIOLTO RESPIMAT (Drug) $44.97
- STIOLTO (Drug) $44.20
- UTIBRON (Drug) $43.63
- BREO (Drug) $40.58
- PREVNAR - 13 (Biological) $25.85
- Esbriet (Biological) $20.26
- OFEV (Drug) $19.46
- NIOX VERO DEVICE (Device) $19.44
- CINQAIR (Drug) $18.67
- TYVASO (Drug) $18.11
- TUDORZA PRESSAIR (Drug) $17.37
- GLASSIA (Biological) $15.92
- Perforomist (Drug) $15.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.